Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00286780
Status:
COMPLETED
Last Update Posted:
2010-08-13
First Post:
2006-02-03
Brief Title:
Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Ascenta Therapeutics